Prevalence of Prescription Opioid Misuse/Abuse as Determined by International Classification of Diseases Codes: A Systematic Review

References

• Substance Abuse and Mental Health Services Administration. Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013. HHS Publication No. (SMA) 13-4760, DAWN Series D-39.
   Google Scholar
• Centers for Disease Control and Prevention. Wide-ranging Online Data for Epidemiologic Research (WONDER), Multiple-Cause-of-Death file, 2000–14. 2015. http://www.cdc.gov/nchs/data/health_policy/AADR_drug_poisoning_involving_OA_Heroin_US_2000-2014.pdf. Accessed February 3, 2016.
   Google Scholar
• Center for Behavioral Health Statistics and Quality. 2014 National Survey on Drug Use and Health: Detailed Tables. Substance Abuse and Mental Health Services Administration, Rockville, MD, 2015.
   Google Scholar
• RM Califf, J Woodcock, S Ostroff. Special report: a proactive response to prescription opioid abuse. N Engl J Med. 2016;374(15):1480–1485. doi: 10.1056/NEJMsr1601307.
   Web of Science ®Google Scholar
• SM Smith, RC Dart, NP Katz, et al. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain. 2013;154:2287–2296.
   PubMed Web of Science ®Google Scholar
• GM Oderda, J Lake, K Rüdell, CL Roland, ET Masters. Economic burden of prescription opioid misuse and abuse: a systematic review. J Pain Palliat Care Pharmacother. 2015;29:388–400.
   PubMedGoogle Scholar
• PL Loney, LW Chambers, KJ Bennett, JG Roberts, PW Stratford. Critical appraisal of the health research literature: prevalence or incidence of a health problem. Chronic Dis Can. 1998;19:170–176.
   PubMedGoogle Scholar
• AG White, HG Birnbaum, M Schiller, T Waldman, JM Cleveland, CL Roland. Economic impact of opioid abuse, dependence, and misuse. Am J Pharm Benefits. 2011;3:e59–e70.
   Google Scholar
• JB Rice, NY Kirson, A Shei, et al. Estimating the costs of opioid abuse and dependence from an employer perspective: a retrospective analysis using administrative claims data. Appl Health Econ Health Policy. 2014;12:435–446.
   PubMedGoogle Scholar
• JB Rice, NY Kirson, A Shei, et al. The economic burden of diagnosed opioid abuse among commercially insured individuals. Postgrad Med. 2014;126:53–58.
   PubMed Web of Science ®Google Scholar
• CL Roland, AV Joshi, J Mardekian, SC Walden, J Harnett. Prevalence and cost of diagnosed opioid abuse in a privately insured population in the United States. J Opioid Manage. 2013;9:161–175.
   PubMedGoogle Scholar
• C McAdam-Marx, CL Roland, J Cleveland, GM Oderda. Costs of opioid abuse and misuse determined from a Medicaid database. J Pain Palliat Care Pharmacother. 2010;24:5–18.
   PubMedGoogle Scholar
• O Baser, L Xie, J Mardekian, D Schaaf, L Wang, AV Joshi. Prevalence of diagnosed opioid abuse and its economic burden in the Veterans Health Administration. Pain Pract. 2014;14:437–445.
   PubMed Web of Science ®Google Scholar
• HS Chandwani, SA Strassels, KL Rascati, KA Lawson, JP Wilson. Estimates of charges associated with emergency department and hospital inpatient care for opioid abuse-related events. J Pain Palliat Care Pharmacother. 2013;27:206–213.
   PubMedGoogle Scholar
• E Michna, NY Kirson, A Shei, HG Birnbaum, R Ben-Joseph. Use of prescription opioids with abuse-deterrent technology to address opioid abuse. Curr Med Res Opin. 2014;30:1589–1598.
   PubMed Web of Science ®Google Scholar
• MJ Edlund, BC Martin, M-Y Fanc M-Y, A Devries, JB Bradenc, MD Sullivan. Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP Study. Drug Alcohol Depend. 2010;112:90–98.
   PubMed Web of Science ®Google Scholar
• BN Cochran, A Flentje, NC Heck, et al. Factors predicting development of opioid use disorders among individuals who receive an initial opioid prescription: mathematical modeling using a database of commercially-insured individuals. Drug Alcohol Depend. 2014;138:202–208.
   PubMed Web of Science ®Google Scholar
• LF Rossiter, NY Kirson, A Shei, et al. Medical cost savings associated with an extended-release opioid with abuse-deterrent technology in the US. J Med Econ. 2014;17:279–287.
   PubMedGoogle Scholar
• RE Palmer, DS Carrell, D Cronkite, et al. The prevalence of problem opioid use in patients receiving chronic opioid therapy: computer-assisted review of electronic health record clinical notes. Pain. 2015;156:1208–1214.
   PubMed Web of Science ®Google Scholar
• R Dufour, AV Joshi, MK Pasquale, et al. The prevalence of diagnosed opioid abuse in commercial and medicare managed care populations. Pain Pract. 2014;14:E106–E115.
   Google Scholar
• M Soledad Cepeda, D Fife, Q Ma, PB Ryan. Comparison of the risks of opioid abuse or dependence between tapentadol and oxycodone: results from a cohort study. J Pain. 2013;14:1227–1241.
   PubMed Web of Science ®Google Scholar
• LJ Paulozzi, K Zhang, CM Jones, KA Mack. Risk of adverse health outcomes with increasing duration and regularity of opioid therapy. J Am Board Fam Med. 2014;27:329–338.
   PubMed Web of Science ®Google Scholar
• TL Mark, J Dilonardo, R Vandivort, K Miller. Psychiatric and medical comorbidities, associated pain, and health care utilization of patients prescribed buprenorphine. J Subst Abuse Treat. 2013;44:481–487.
   PubMed Web of Science ®Google Scholar
• SA Strassels. Economic burden of prescription opioid misuse and abuse. J Manag Care Pharm. 2009;15:556–562.
   PubMed Web of Science ®Google Scholar
• AM Secora, CM Dormitzer, JA Staffa, GJ Dal Pan. Measures to quantify the abuse of prescription opioids: a review of data sources and metrics. Pharmacoepidemiol Drug Saf. 2014;23:1227–1237.
   PubMed Web of Science ®Google Scholar
• G Oderda, C Roland, V Stevens, X Ye. Prevalence and direct costs of opioid abuse in Medicare beneficiaries. J Manag Care Spec Pharm. 2015;21:S71–S72.
   Google Scholar
• DS Carrell, D Cronkite, RE Palmer, et al. Using natural language processing to identify problem usage of prescription opioids. Int J Med Informatics. 2015;84:1057–1064.
   PubMed Web of Science ®Google Scholar